Dysfunction of
NMDA receptor (NMDAR)-mediated transmission is supposed to contribute to the motor and non-motor symptoms of
Parkinson's Disease (PD), and to
L-DOPA-induced
dyskinesia. Besides the main agonist
L-glutamate, two other
amino acids in the atypical D-configuration, D-
serine and
D-aspartate, activate NMDARs. In the present work, we investigated the effect of
dopamine depletion on D-
amino acids metabolism in the brain of
MPTP-lesioned Macaca mulatta, and in the serum and cerebrospinal fluid of PD patients. We found that
MPTP treatment increases
D-aspartate and D-
serine in the monkey putamen while
L-DOPA rescues both D-
amino acids levels. Conversely, dopaminergic
denervation is associated with selective D-
serine reduction in the substantia nigra. Such decrease suggests that the beneficial effect of D-
serine adjuvant
therapy previously reported in PD patients may derive from the normalization of endogenous D-
serine levels and consequent improvement of nigrostriatal hypoglutamatergic transmission at
glycine binding site. We also found reduced D-
serine concentration in the cerebrospinal fluid of
L-DOPA-free PD patients. These results further confirm the existence of deep interaction between dopaminergic and glutamatergic neurotransmission in PD and disclose a possible direct influence of D-
amino acids variations in the changes of NMDAR transmission occurring under
dopamine denervation and
L-DOPA therapy.